A048530 Stock Overview
iNtRON Biotechnology, Inc. develops biopharmaceuticals for the prevention and treatment of human diseases worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 1/6 |
| Past Performance | 4/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for A048530 from our risk checks.
My Notes
NewNotes are coming soon
iNtRON Biotechnology, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩8,650.00 |
| 52 Week High | ₩23,300.00 |
| 52 Week Low | ₩7,790.00 |
| Beta | 0.68 |
| 1 Month Change | 3.22% |
| 3 Month Change | -0.23% |
| 1 Year Change | -50.85% |
| 3 Year Change | -26.38% |
| 5 Year Change | -60.82% |
| Change since IPO | 116.25% |
Recent News & Updates
Recent updates
We Think iNtRON Biotechnology (KOSDAQ:048530) Can Stay On Top Of Its Debt
May 03
We Believe iNtRON Biotechnology's (KOSDAQ:048530) Earnings Are A Poor Guide For Its Profitability
Mar 24Does iNtRON Biotechnology's (KOSDAQ:048530) Share Price Gain of 81% Match Its Business Performance?
Feb 28iNtRON Biotechnology, Inc.'s (KOSDAQ:048530) Stock Is Going Strong: Is the Market Following Fundamentals?
Jan 31
iNtRON Biotechnology (KOSDAQ:048530) Has A Rock Solid Balance Sheet
Jan 05What iNtRON Biotechnology, Inc.'s (KOSDAQ:048530) 26% Share Price Gain Is Not Telling You
Dec 10iNtRON Biotechnology (KOSDAQ:048530) Share Prices Have Dropped 49% In The Last Five Years
Nov 26Shareholder Returns
| A048530 | KR Biotechs | KR Market | |
|---|---|---|---|
| 7D | 1.8% | 0.6% | 3.8% |
| 1Y | -50.9% | -20.2% | -6.9% |
Return vs Industry: A048530 underperformed the KR Biotechs industry which returned -20.2% over the past year.
Return vs Market: A048530 underperformed the KR Market which returned -6.9% over the past year.
Price Volatility
| A048530 volatility | |
|---|---|
| A048530 Average Weekly Movement | 6.1% |
| Biotechs Industry Average Movement | 6.6% |
| Market Average Movement | 5.4% |
| 10% most volatile stocks in KR Market | 10.6% |
| 10% least volatile stocks in KR Market | 3.1% |
Stable Share Price: A048530 is not significantly more volatile than the rest of KR stocks over the past 3 months, typically moving +/- 6% a week.
Volatility Over Time: A048530's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 87 | Alek Yoon | https://www.intron.co.kr |
iNtRON Biotechnology, Inc. develops biopharmaceuticals for the prevention and treatment of human diseases worldwide. It develops bacteriophage and endoricin drugs. The company was founded in 1999 and is headquartered in Seongnam-si, South Korea.
iNtRON Biotechnology, Inc. Fundamentals Summary
| A048530 fundamental statistics | |
|---|---|
| Market Cap | ₩289.24b |
| Earnings (TTM) | ₩11.83b |
| Revenue (TTM) | ₩19.68b |
24.5x
P/E Ratio14.7x
P/S RatioIs A048530 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A048530 income statement (TTM) | |
|---|---|
| Revenue | ₩19.68b |
| Cost of Revenue | ₩5.22b |
| Gross Profit | ₩14.46b |
| Other Expenses | ₩2.63b |
| Earnings | ₩11.83b |
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | 352.98 |
| Gross Margin | 73.46% |
| Net Profit Margin | 60.11% |
| Debt/Equity Ratio | 16.5% |
How did A048530 perform over the long term?
See historical performance and comparison